top of page
  • Composition of active substances in 1 ml:

     

    Inactivated bluetongue virus, serotype 4 (BTV-4), strain BTV-4/SPA-1/2004
    RP* _ 1
    Inactivated bluetongue virus, serotype 8 (BTV-8), strain BEL2006/01
    RP* _ 1
    * Relative potency measured by ELISA in relation to a reference vaccine
    whose efficacy has been demonstrated by challenge in the target species.
    Adjuvant:
    Aluminum hydroxide (Al3+) 2.08 mg
    Semi-puri_ed saponin from Quillaja Saponaria 0.2 mg


    Preservative:
    Thiomersal 0.1 mg

     

    Labels:

     

    Sheep:
    For active vaccination of sheep, to prevent viremia (viral infection in the blood) and reduce signs
    and reducing viremia (clinical bluetongue virus serotype 8 infection, as a result of a virus
    bluetongue virus serotype 4 viral in the blood) and clinical signs, as a result of a virus
    Onset of immunity: 39 days after completion of primary vaccination.
    Duration of immunity: one year from the completion of the initial vaccination.


    Beef:
    For active vaccination of cattle to prevent viremia (viral infection in the blood), as a result of a virus
    and reducing viremia (viral infection in the blood) as a result of bluetongue virus serotype 8
    bluetongue virus serotype 4
    Onset of immunity: 21 days after completion of the primary vaccination.
    Duration of immunity: one year from the completion of the initial vaccination.


    Contraindications:
    nothing.


    Side Effects :
    Local reactions at the injection site are very common after vaccination.
    It is very common that redness or slight swelling will develop within 1-6 days after the injection
    medium
    Painless swelling that can reach a diameter of up to 3.8 cm in sheep or 7 cm in cattle
    Common 2-6 days after vaccination. The swelling will gradually decrease. will rarely develop
    A purulent lesion instead.
    Most of the local phenomena (under 1 cm), will disappear or be negligible within 70 days
    From the injection to sheep or 30 days after the injection to cattle.
    2.3° within 48 hours from the date of vaccination is very common. C Increase in rectal temperature up to
    The following phenomena may occur in rare cases in sheep or very rarely in cattle:
    Disorders in the reproductive system (abortions, fetal death, premature birth).
    Systemic disorders: apathy, recumbency, fever, anorexia, exhaustion.
    Very rare side effects in sheep and cattle:
    Decreased milk production.
    Neurological disorders (paralysis, lack of muscle control, blindness, and lack of coordination).
    Respiratory system disorders (pulmonary congestion, difficulty breathing).
    (Rumen Atony, digestive system disorders (swelling
    hypersensitivity reaction.
    death

    The frequency of side effects is defined according to the following conventions:
    Appear in more than 1 out of 10 owners (very common) very common side effects
    Life is treated.
    1 out of 100 animals - appear in 10 (common) common side effects
    Patients.
    1 in 1,000 owners - appear in 10 (uncommon) - side effects that are not common
    Life is treated.
    1 in 10,000 treated animals. - appear in 10 (rare) rare side effects
    Appear in less than one animal out of (very rare) very rare side effects
    10,000 animals treated, including individual reports.
    Overdose - when giving a double dose, no side effects unusual to those described were observed
    In the side effects section.


    Target gender:
    sheep and cattle.
    Dosage, manner and method of administration, preparation instructions/proper use of the ingredient:
    Shake well before use.
    For sheep from the age of 3 months according to the following plan: S.C. Sheep: subcutaneous administration
    Primary vaccination - administration of one dose of 2 ml.
    Revaccination - after 12 months, giving one dose of 2 ml.
    From the age of 2 months to calves born from unvaccinated mothers, I.M. Cattle: intramuscular administration
    or from the age of 3 months for calves born from vaccinated mothers, according to the following plan:
    Primary vaccination - administration of two doses of 4 ml each, with an interval of three weeks
    between dishes.
    Revaccination - after 12 months, giving one dose of 4 ml.

    Standby time:
    zero days

     

    storage instructions:
    out of reach of children.
    2-8°C should be stored and transported refrigerated at a temperature of
    After opening: the entire contents of the bottle must be used within 10 hours or disposed of.
    Do not freeze.
    Protect from light.
    Must be stored in the original packaging.
    Do not use the ingredient after the expiration date shown on the package.
    Special warnings and precautions
    Only sterile syringes and needles should be used.
    Keep out of the reach of children.


    Warnings for use in animals:
    Only healthy animals should be vaccinated. Maintain aseptic conditions during product use.
    Cattle bearing BTV 4 antibodies have no information on administration of the formulation containing the serotype
    motherly

    Warnings to the warehouse person:
    If you have been accidentally injected with this product, seek immediate medical advice and present the leaflet to the doctor
    or the ingredient label.
    Avoid contact of the product with people who are sensitive to the product or its components - aluminum
    hydroxide, thiomersal and saponins.
    For animal use only.

    Use during pregnancy:
    The product can be used during pregnancy in sheep and cattle.
    Can be used during emulsification.
    The safety and efficacy of the compound have not been proven in males intended for breeding.
    Incompatibilities and reactions between drugs:
    Do not mix this ingredient with another veterinary preparation.
    No information is available on the safety and effectiveness of the simultaneous use of this ingredient with any
    Make another. The decision regarding the use of this ingredient before or after a veterinary preparation
    Otherwise, it should be done on a case-by-case basis.

    Type and contents of packaging:
    A cardboard box with one polypropylene bottle with a volume of 80 ml (40 servings for sheep, 20
    dishes to visit).
    A cardboard box with one polypropylene bottle with a volume of 200 ml (100 servings for sheep, 50
    dishes to visit).
    Not all package sizes may be marketed.
    Instructions for destroying waste, packaging and materials originating from the use of a medical preparation


    veterinary:
    Any residue of a veterinary ingredient or any waste obtained from the use of a veterinary ingredient
    Must be destroyed as infectious waste. Do not dispose of in the sewer.

     

    containing:
    200 ml

    Syvazul BTV

    bottom of page